Rocket Pharmaceuticals (RCKT) Capital Leases (2020 - 2026)
Rocket Pharmaceuticals (RCKT) posted Capital Leases of $19.33 million for Q2 2026, down 0.3% from $19.38 million a year earlier and down 0.1% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Capital Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, Rocket Pharmaceuticals' Capital Leases came in at $19.36 million, down 0.1% from FY2024.
- Annual Capital Leases shows a five-year compound annual growth rate of 0.4% (FY2020 to FY2025).
- In prior years, Rocket Pharmaceuticals' Capital Leases was $19.38 million in FY2024 (+0.2%), $19.35 million in FY2023 (+0.4%), $19.27 million in FY2022 (+0.7%) and $19.14 million in FY2021 (+0.8%).
- The Q2 2026 figure stands as the lowest quarterly Capital Leases since Q2 2023.
- On a year-over-year basis, Capital Leases has declined in each of the last three quarters, with an average year-over-year change of 0.0% over the last eight quarters.
- The strongest year-over-year quarter for Capital Leases in the past five years was Q3 2021, with growth of 0.9%; the weakest was Q2 2026, with a decline of 0.3%.
- According to Business Quant data, Capital Leases for the three prior quarters was $19.35 million (Q1 2026), $19.36 million (Q4 2025) and $19.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Rocket Pharmaceuticals | 268.37 Mn | -15.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.33 Mn |
| Mar 31, 2026 | 19.35 Mn |
| Dec 31, 2025 | 19.36 Mn |
| Sep 30, 2025 | 19.38 Mn |
| Jun 30, 2025 | 19.38 Mn |
| Mar 31, 2025 | 19.38 Mn |
| Dec 31, 2024 | 19.38 Mn |
| Sep 30, 2024 | 19.38 Mn |
| Jun 30, 2024 | 19.37 Mn |
| Mar 31, 2024 | 19.36 Mn |
| Dec 31, 2023 | 19.35 Mn |
| Sep 30, 2023 | 19.34 Mn |
| Jun 30, 2023 | 19.32 Mn |
| Mar 31, 2023 | 19.29 Mn |
| Dec 31, 2022 | 19.27 Mn |
| Sep 30, 2022 | 19.24 Mn |
| Jun 30, 2022 | 19.21 Mn |
| Mar 31, 2022 | 19.18 Mn |
| Dec 31, 2021 | 19.14 Mn |
| Sep 30, 2021 | 19.11 Mn |
API Access
Rocket Pharmaceuticals Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();